Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging
- PMID: 9852880
Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging
Abstract
Background: The identification of high-risk patients who require early revascularization has become increasingly important with the present emphasis on reducing health care resources. This is particularly relevant to health care systems with prolonged waiting times for interventions. Myocardial viability imaging with the use of fluorine 18-fluorodeoxyglucose (FDG) PET may help to identify high-risk patients with severe left ventricular dysfunction. The aim of this study was to evaluate the consequences of prolonged waiting time on cardiac outcomes in patients with left ventricular dysfunction directed to revascularization based on FDG PET imaging.
Methods and results: Forty-six patients with coronary disease and an ejection fraction of < or = 35% were considered candidates for revascularization based on FDG PET viability imaging. Thirty-five of 46 patients were subsequently accepted for revascularization. Patients were divided into 2 groups based on the median waiting time after PET: an early group (< 35 days; n = 18) and a late group (> or = 35 days; n = 17). Preoperative mortality rates were significantly increased in the late group (4 of 17 [24%] versus 0 of 18 in the early group; P < 0.05). In postoperative follow-up (17 +/- 7 months), cardiac events occurred in 2 of 18 (11%) and 1 of 13 (7.8%) patients in the early and late groups, respectively. Left ventricular ejection fraction increased after early revascularization (24 +/- 7% to 29 +/- 8%, P < 0.001, baseline versus 3 months) but not in the late group (27 +/- 5% to 28 +/- 6%, P = NS).
Conclusions: Preoperative FDG PET can be used to identify a high-risk group of patients who may benefit from early revascularization. A long waiting time for revascularization is associated with a high mortality rate and suggests that early revascularization is desirable after the identification of hibernating viable myocardium.
Similar articles
-
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.Circ Cardiovasc Imaging. 2013 May 1;6(3):363-72. doi: 10.1161/CIRCIMAGING.112.000138. Epub 2013 Apr 17. Circ Cardiovasc Imaging. 2013. PMID: 23595888
-
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.JACC Cardiovasc Imaging. 2009 Sep;2(9):1060-8. doi: 10.1016/j.jcmg.2009.02.017. JACC Cardiovasc Imaging. 2009. PMID: 19761983 Clinical Trial.
-
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.Circ Cardiovasc Imaging. 2016 Sep;9(9):e004331. doi: 10.1161/CIRCIMAGING.115.004331. Circ Cardiovasc Imaging. 2016. PMID: 27609816 Clinical Trial.
-
Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease.Semin Thorac Cardiovasc Surg. 1995 Oct;7(4):214-26. Semin Thorac Cardiovasc Surg. 1995. PMID: 8590746 Review.
-
18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.Semin Nucl Med. 2000 Oct;30(4):281-98. doi: 10.1053/snuc.2000.9543. Semin Nucl Med. 2000. PMID: 11105929 Review.
Cited by
-
Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1709-24. doi: 10.1007/s00259-008-0859-1. Epub 2008 Jun 26. Eur J Nucl Med Mol Imaging. 2008. PMID: 18581113 Review.
-
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):309-15. doi: 10.1007/s00259-006-0235-y. Epub 2006 Sep 26. Eur J Nucl Med Mol Imaging. 2007. PMID: 17021810
-
PET and SPECT in heart failure.Curr Cardiol Rep. 2013 Mar;15(3):337. doi: 10.1007/s11886-012-0337-z. Curr Cardiol Rep. 2013. PMID: 23338719 Review.
-
Viability assessment with MRI is superior to FDG-PET for viability: Con.J Nucl Cardiol. 2010 Apr;17(2):298-309. doi: 10.1007/s12350-010-9209-3. J Nucl Cardiol. 2010. PMID: 20229106 No abstract available.
-
Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women.J Nucl Cardiol. 2000 May-Jun;7(3):205-12. doi: 10.1016/s1071-3581(00)70008-0. J Nucl Cardiol. 2000. PMID: 10888390
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous